The committee will discuss, make recommendations and vote on a premarket approval application (PMA) for the Scandinavian Total Ankle Replacement System, sponsored by Link America, Inc. This system is intended for use as a non-cemented implant to repl…

continue reading.....

Article reprinted from Nursing2008, August issue.

continue reading.....

A new study in low-risk, elective-PCI patients who were also nonresponsive to aspirin and/or clopidogrel shows that adding tirofiban during PCI can cut MI rates by more than 40%, as compared with patients given a placebo infusion.
Heartwire

continue reading.....

The findings support a strategy of first testing patients for persistent viral load before choosing a treatment strategy.
Heartwire

continue reading.....

Panacea Pharmaceuticals, Inc. has announced the issuance of U.S. Patent Number 7,413,737 covering antibodies against human aspartyl (asparaginyl) beta-hydroxylase (HAAH), a proprietary human cancer biomarker and therapeutic target.

continue reading.....

Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).

continue reading.....

Alte Bioscience, Inc., a development stage pharmaceutical company, is pleased to announce the filing of a provisional patent for a new class of drugs that may benefit patients with inflammatory bowel disease.

continue reading.....

For the 5% to 10% of adults who fail to mount an adequate response to the standard hepatitis B virus (HBV) vaccine regimen, a double dose of the combined hepatitis A and B vaccine may turn these nonresponders into responders, results of a study from Sweden suggest.
Reuters Health Information

continue reading.....

Australian researchers report a higher rate of anaphylaxis with the HPV vaccine than has been seen with other vaccines, but they note that there were no serious sequelae and the overall rate was very low.
Medscape Medical News

continue reading.....

Omega-3 fatty-acid supplementation improved morbidity and mortality in symptomatic heart-failure patients, while statins failed to have any beneficial effect in the same group of patients.
Medscape Medical News

continue reading.....